On ECHEMI
Home > Drugs > Jinan Hengji Pharmaceutical Co., Ltd.
Jinan Hengji Pharmaceutical Co., Ltd.
  • Founded in:

    2002-11-19
  • Country:

    China China
  • Address:

    Room 301, North Building, No. 29, Honglou West Road, Hongjialou Street, Licheng District, Jinan City, Shandong Province
  • Tax NO.:

    9137010074453294XX
  • Registered Funds:

    11.24 million yuan
  • Email:

Related Drugs
Clozapine Tablets
The main ingredient of this product is clozapine, and its chemical name is: 8-chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo[b,e][1,4]diazepine.
Name Description Content CAS NO. Registered Holders
Clozapine

This product is a dibenzodiazepine antipsychotic. It has a strong blocking effect on the 5-hydroxytryptamine (5-HT2A) receptor and dopamine (DA1) receptor in the brain, and also has a blocking effect on the dopamine (DA4) receptor, and a weaker blocking effect on the dopamine (DA2) receptor. In addition, it also has anticholinergic (M1), antihistamine (H1) and anti-α-adrenaline receptor effects. Extrapyramidal reactions are rare, and generally do not cause an increase in blood prolactin. It can directly inhibit the ascending activation system of the brainstem reticular formation and has a strong sedative and hypnotic effect.

More

This product is a dibenzodiazepine antipsychotic. It has a strong blocking effect on the 5-hydroxytryptamine (5-HT2A) receptor and dopamine (DA1) receptor in the brain, and also has a blocking effect on the dopamine (DA4) receptor, and a weaker blocking effect on the dopamine (DA2) receptor. In addition, it also has anticholinergic (M1), antihistamine (H1) and anti-α-adrenaline receptor effects. Extrapyramidal reactions are rare, and generally do not cause an increase in blood prolactin. It can directly inhibit the ascending activation system of the brainstem reticular formation and has a strong sedative and hypnotic effect.

5786-21-0 30
Compound Paracetamol and Amantadine Capsules
This product is a compound preparation, each tablet contains 250 mg of acetaminophen, 100 mg of amantadine hydrochloride, 2 mg of chlorpheniramine maleate, 10 mg of artificial bezoar, and 15 mg of caffeine. The auxiliary material is starch.
Name Description Content CAS NO. Registered Holders
Acetaminophen

It can inhibit the synthesis of prostaglandins and has antipyretic and analgesic effects

More

It can inhibit the synthesis of prostaglandins and has antipyretic and analgesic effects

250mg 103-90-2 68
1-Adamantanamine hydrochloride

Can resist subtype I influenza virus and inhibit virus reproduction

More

Can resist subtype I influenza virus and inhibit virus reproduction

100mg 665-66-7 13
Chlorphenamine maleate

Can relieve symptoms such as runny nose, nasal congestion, sneezing, etc.

More

Can relieve symptoms such as runny nose, nasal congestion, sneezing, etc.

2mg 113-92-8 28
Atificial Cow-bezoar

It has antipyretic and sedative effects

More

It has antipyretic and sedative effects

10mg 1002-00-2 2
Caffeine

It is a central nervous system stimulant that can enhance the antipyretic and analgesic effects of acetaminophen and reduce central nervous system inhibitory effects such as drowsiness and dizziness caused by other drugs.

More

It is a central nervous system stimulant that can enhance the antipyretic and analgesic effects of acetaminophen and reduce central nervous system inhibitory effects such as drowsiness and dizziness caused by other drugs.

15mg 0
Naoluotong Capsule
Salvia miltiorrhiza, Ligusticum chuanxiong, Astragalus membranaceus, Methyl hesperidin, Tolperisone hydrochloride, Vitamin B.
Name Description Content CAS NO. Registered Holders
Salvia Root P.E Tanshinone IIA 20%

0
Riligustilide

89354-45-0 0
Astragali Radix

0
Methyl hesperidin

11013-97-1 3
Tolperisone hydrochloride

3644-61-9 9
Vitamin B series

0
Nitrofurantoin enteric-coated tablets
The main ingredient of this product is nitrofurantoin.
Name Description Content CAS NO. Registered Holders
Nitrofurantoin

This product is an antibacterial drug. Escherichia coli is mostly sensitive to this product, and some strains of Enterobacteriaceae such as Enterobacter aerogenes, Enterobacter cloacae, Proteus, and Klebsiella are sensitive to this product. Aeruginosa is usually resistant to this product. This product has antibacterial effects on Gram-positive bacteria such as Enterococcus. The antibacterial activity of this product is not affected by pus and tissue decomposition products. It is more active in acidic urine. The antibacterial mechanism is to interfere with the oxidoreductase system in the bacteria, thereby blocking its metabolic process.

More

This product is an antibacterial drug. Escherichia coli is mostly sensitive to this product, and some strains of Enterobacteriaceae such as Enterobacter aerogenes, Enterobacter cloacae, Proteus, and Klebsiella are sensitive to this product. Aeruginosa is usually resistant to this product. This product has antibacterial effects on Gram-positive bacteria such as Enterococcus. The antibacterial activity of this product is not affected by pus and tissue decomposition products. It is more active in acidic urine. The antibacterial mechanism is to interfere with the oxidoreductase system in the bacteria, thereby blocking its metabolic process.

67-20-9 26
Isosorbide Mononitrate Capsules
The chemical name of this product is: 1,4:3,6-dianhydro-D-sorbitol-5-mononitrate.
Name Description Content CAS NO. Registered Holders
Isosorbide 5-mononitrate

It relaxes vascular smooth muscle, activates guanylate cyclase by releasing nitric oxide (NO), increases cyclic guanosine monophosphate (cGMP) in smooth muscle cells, thereby dilating peripheral arteries and veins, reducing venous return, left ventricular end-diastolic pressure, pulmonary capillary wedge pressure, peripheral vascular resistance, systolic arterial pressure and mean arterial pressure, increasing coronary artery perfusion and reducing myocardial oxygen consumption.

More

It relaxes vascular smooth muscle, activates guanylate cyclase by releasing nitric oxide (NO), increases cyclic guanosine monophosphate (cGMP) in smooth muscle cells, thereby dilating peripheral arteries and veins, reducing venous return, left ventricular end-diastolic pressure, pulmonary capillary wedge pressure, peripheral vascular resistance, systolic arterial pressure and mean arterial pressure, increasing coronary artery perfusion and reducing myocardial oxygen consumption.

16051-77-7 23
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.